NEWS

Back to homepage
NEWS

NICE approves life-changing gene therapy for treating spinal muscular atrophy

A new and potentially curative one-off gene therapy for babies with the rare genetic disorder spinal muscular atrophy (SMA) is set to become the most expensive treatment ever approved by

COMPANY NEWS NEWS

NuVasive and the International Spine Study Group Foundation announce expanded long-term partnership with initiation of additional clinical studies

NuVasive, a spine technology innovation company, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, and the International Spine Study Group Foundation (ISSGF) recently announced the continuation of

NEWS

Patients should receive COVID-19 vaccine before surgery to reduce risk of postoperative death

Patients waiting for elective surgery should get COVID-19 vaccines ahead of the general population – potentially helping to avoid thousands of post-operative deaths linked to the virus, according to a

NEWS PRODUCT NEWS

ATHLET® – Cervical vertebral body replacement

Promotional feature ATHLET® is a vertebral body replacement implant used for stabilisation and reconstruction of the cervical spine (C3 – C7). It is used following cervical corpectomy with anterior access

COMPANY NEWS NEWS

Mainstay Medical announces commercial launch of ReActiv8 in Australia

Mainstay Medical Holdings recently announced the commercial launch in Australia of ReActiv8®, its implantable neurostimulation system to treat chronic low back pain. “Launching ReActiv8, our Restorative Neurostimulation therapy, commercially in Australia

NEWS

Covid positive patients should delay surgery to reduce death risk

Surgery should be delayed for seven weeks after a patient tests positive for COVID-19 – as operations taking place up to six weeks after diagnosis are associated with increased risk

COMPANY NEWS NEWS

MedTech start-up, Axis Spine Technologies, completes £2.2m funding round led by ACF Investors

Axis Spine Technologies Ltd (AST) has raised £2.2m in a funding round led by ACF Investors, with follow-on investment from Mercia’s EIS funds. Mercia was the first investor when Axis

NEWS

New potential for functional recovery after spinal cord injury

Researchers at Indiana University School of Medicine have successfully reprogrammed a glial cell type in the central nervous system into new neurons to promote recovery after spinal cord injury, revealing

NEWS

Scientists repair injured spinal cord using patients’ own stem cells

Intravenous injection of bone marrow derived stem cells (MSCs) in patients with spinal cord injuries led to significant improvement in motor functions, researchers from Yale University and Japan report Feb.

NEWS PRODUCT NEWS

ASCOT – Anterior Cervical Stabilisation

Promotional feature In 2005, the first SIGNUS plate for anterior cervical stabilisation was launched: TOSCA. In 2015 SIGNUS expanded its product range for the cervical spine: ASCOT is a system